Eiji Ishikawa

1.2k citations
65 papers · 611 indexed · h-index 12
Topics
Renal Diseases and Glomerulopathies (12 papers)Dialysis and Renal Disease Management (11 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers)
Partner nations
JapanSwedenFinland

In The Last Decade

Eiji Ishikawa

62 papers receiving 588 citations

Peers

Eiji Ishikawa
Comparison fields: 5 of 87
  • Nephrology 227
  • Molecular Biology 107
  • Hematology 99
  • Surgery 94
  • Pulmonary and Respiratory Medicine 94
Replace Reiichi Murakami with:
Reiichi Murakami Japan
Harald Althaus Germany
Mark A. Lusco United States
Marta Lapsley United Kingdom
M Beaufils France
Wei Qin China
Edmond O’Riordan United Kingdom
Yusuke Watanabe Japan
Gisella Vischini Italy
Go Kanzaki Japan
Eiji Ishikawa relative to Reiichi Murakami Japan Reiichi Murakami's profile →
Citations per field
00.5×3.1×
Reiichi Murakami · 1×
Citations per year

Countries citing papers authored by Eiji Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Eiji Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Ishikawa more than expected).

Fields of papers citing papers by Eiji Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Ishikawa. The network helps show where Eiji Ishikawa may publish in the future.

Co-authorship network of co-authors of Eiji Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Ishikawa. A scholar is included among the top collaborators of Eiji Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Ishikawa. Eiji Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 24
5 1
6 15
7 11
8 0
9 3
10 6
11 7
12 6
13 1
14 1
15 5
16 2
17 11
18 14
19 4
20 8

About Eiji Ishikawa

Eiji Ishikawa is a scholar working on Nephrology, Hematology and Genetics, having authored 65 papers that have together received 611 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (12 papers), Dialysis and Renal Disease Management (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers). The work is most often cited by research in Nephrology (227 citations), Hematology (99 citations) and Genetics (55 citations). Eiji Ishikawa has collaborated with scholars based in Japan, Sweden and Finland. Frequent co-authors include Masaaki Ito, Shinsuke Nomura, Kan Katayama, Tomohiro Murata, Hisako Matsutaka, Tadaomi Aikawa, T NAKATANI, M. Nagashima, Kensaku Dote and Susumu Hagiwara. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026